Evaluation of efficacy of dose escalation strategy for treatment with sorafenib for hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 Apr 2017 Status changed from recruiting to completed.
- 02 Nov 2012 New trial record